Elizabeth Bukusi

Scientific Advisory Board


KEMRI/Wellcome Trust Research Programme (KWTRP) Kilifi, Kenya

Collaboration Interests
  • Bioethics
  • HIV co morbidity care
  • Sexual Reproductive Health (SHR)
  • STI/HIV prevention

Elizabeth Bukusi earned her general medical degree and Masters in Obstetrics and Gynaecology degree from the University of Nairobi in Kenya. She then acquired a MPH and PhD from the University of Washington’s Department of Epidemiology in the USA, and a post graduate diploma in Research Ethics from the University of Cape Town, Western Cape, South Africa, and a Masters in Bioethics from Centre for Bioethics and Culture at the Sind Institute of Urology and Transplantation in Karachi, Pakistan. She is a Chief Research Officer, Senior Principal Clinical Research Scientist, and an Associate Research Professor at the University of Washington (Departments of Obstetrics and Gynaecology and Global Health), an honorary lecturer at Aga Khan University in Nairobi (Department of Obstetrics and Gynaecology), and Volunteer Clinical Faculty – Associate Professor at the University of California San Francisco, USA (Department of Obstetrics, Gynaecology & Reproductive Sciences). Her primary areas of interest in research focus on sexually transmitted infections, reproductive health, and HIV prevention, care, and treatment. She was a member of the Kenya National AIDS Control Council HIV Prevention Task force and served on the World Health Organisation’s (WHO’s) Department of Reproductive Health’s Scientific Technical Advisory Board (STAG 2008-2014) and previously Chaired the WHO UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP) Alliance . She served as a member of the Board of Management of the South African Medical Research Council and is an elected Fellow of the African Academy of Sciences.

SANTHE is an Africa Health Research Institute (AHRI) flagship programme funded by the Science for Africa Foundation through the DELTAS Africa programme; the Bill & Melinda Gates Foundation; Gilead Sciences Inc.; and the Ragon Institute of Mass General, MIT, and Harvard.